These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 524230)
1. [Advances in the epidemiology of infection in the granulocytopenic patient (author's transl)]. Garau Alemany J Sangre (Barc); 1979; 24(5B):836-44. PubMed ID: 524230 [No Abstract] [Full Text] [Related]
2. [Prophylaxis of infections in granulocytopenic patients (author's transl]. Grañena A; Rozman C; Aranalde JM; Feliú E; García J; Marín P; Montserrat-Costa E; Ribas Mundo M; Matutes E Sangre (Barc); 1979; 24(5B):857-67. PubMed ID: 524232 [No Abstract] [Full Text] [Related]
3. [Granulocyte transfusion. Its efficacy as a complementary treatment of infections in the granulocytopenic patient (author's transl)]. Vivancos Pujol MP; Alemany A; Clavo M; Rubio Baget A; Sans Botargues R; Ferran C Sangre (Barc); 1979; 24(5B):896-903. PubMed ID: 524234 [No Abstract] [Full Text] [Related]
4. [The effectiveness of granulocyte transfusions in the treatment of severe injections in granulocytopenic patients. A controlled trial (author's transl)]. Grañena A; Aranalde JM; Feliu E; Muncunill J; Montserrat E; Hernandez Nieto L; Rozman C Sangre (Barc); 1978; 23(3):291-7. PubMed ID: 675453 [No Abstract] [Full Text] [Related]
5. Prophylaxis in severe granulocytopenia. Thompson EI; Callihan TR; Mauer AM Adv Intern Med; 1984; 29():193-214. PubMed ID: 6369925 [No Abstract] [Full Text] [Related]
6. [Considerations on the use of granulocytes obtained by intermittent flow centrifugation [IFC] in the transfusion to granulocytopenic patients (author's transl)]. Fernández MN; Barbolla L; Sanjuan I; Cabrera R; Regidor MC; Pérez Alvarez L; Zabala P Sangre (Barc); 1979; 24(5B):878-95. PubMed ID: 524233 [No Abstract] [Full Text] [Related]
7. [Acute drug-induced agranulocytosis: comparison between openward treatment and antimicrobial decontamination in a plastic isolation bed system (retrospective study of 30 cases) (author's transl)]. Abt C; Dietrich M; Niethammer D; Arnold R; Pflieger H; Töllner U; Vanek E; Kubanek B; Kleihauer E; Heimpel H Dtsch Med Wochenschr; 1978 Jan; 103(3):108-14. PubMed ID: 624249 [TBL] [Abstract][Full Text] [Related]
9. Management of infections in immunocompromised cancer patients. Bajetta E; Gasparini G; Monfardini S; Volonterio A; Buzzoni R; Shinde S Haematologica; 1984; 69(5):576-97. PubMed ID: 6437936 [No Abstract] [Full Text] [Related]
10. Fever in the patient with cancer. Pathophysiology and the initial evaluation and management. Gutiérrez-Nuñez JJ Bol Asoc Med P R; 1984 Jun; 76(6):256-64. PubMed ID: 6380516 [No Abstract] [Full Text] [Related]
11. Prophylaxis and treatment of infection of the immunocompromised host by granulocyte transfusions. Buckner CD; Clift RA Clin Haematol; 1984 Oct; 13(3):557-72. PubMed ID: 6388932 [TBL] [Abstract][Full Text] [Related]
12. Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients. A report of the EORTC International Antimicrobial Therapy Project Group. Gaya H Schweiz Med Wochenschr Suppl; 1983; 14():49-57. PubMed ID: 6361992 [TBL] [Abstract][Full Text] [Related]
13. [Blood cultures-bacteriological and drug resistance culture (author's transl)]. Moreno G; Granado C; Lopes CA; de Campos CE Arq Inst Biol (Sao Paulo); 1975; 42():233-8. PubMed ID: 1236053 [TBL] [Abstract][Full Text] [Related]
14. Three antibiotic regimens in the treatment of infection in febrile granulocytopenic patients with cancer. The EORTC international antimicrobial therapy project group. Schimpff SC; Gaya H; Klastersky J; Tattersall MH; Zinner SH J Infect Dis; 1978 Jan; 137(1):14-29. PubMed ID: 624850 [No Abstract] [Full Text] [Related]
15. Perils of prophylaxis. Jacoby GA N Engl J Med; 1982 Jan; 306(1):43-4. PubMed ID: 7053471 [No Abstract] [Full Text] [Related]
16. Granulocyte transfusion therapy. Dutcher JP Am J Med Sci; 1984; 287(2):11-7. PubMed ID: 6711583 [TBL] [Abstract][Full Text] [Related]
18. Rational basis for the choice of regimens for empirical therapy of sepsis in granulocytopenic patients. Gaya H Clin Haematol; 1984 Oct; 13(3):573-86. PubMed ID: 6388933 [TBL] [Abstract][Full Text] [Related]
19. The management of febrile episodes in-neutropenic cancer. Bishop JF; McLennan R; Whiteside MG Med J Aust; 1977 Apr; 1(14):473-5. PubMed ID: 865367 [TBL] [Abstract][Full Text] [Related]
20. [Use of multidiscs for determination of polyresistance of microorganisms to antibiotics (author's transl)]. Antal M; Paulíková B; Janousková J; Krcméry V; Stĕpánková E; Baláziková M Cesk Epidemiol Mikrobiol Imunol; 1975 May; 24(3):129-35. PubMed ID: 126810 [No Abstract] [Full Text] [Related] [Next] [New Search]